Literature DB >> 20074553

IL-1-induced ERK1/2 activation up-regulates p21(Waf1/Cip1) protein by inhibition of degradation via ubiquitin-independent pathway in human melanoma cells A375.

Tomohiro Arakawa1, Hidetoshi Hayashi, Saotomo Itoh, Takemasa Takii, Kikuo Onozaki.   

Abstract

IL-1 inhibits the proliferation of human melanoma cells A375 by arresting the cell cycle at G0/G1 phase, which accompanies the increase of p21(Waf1/Cip1) (p21) protein. Here, we demonstrate that IL-1 induces the stabilization of p21 protein via ERK1/2 pathway. The degradation of p21 was inhibited by IL-1, however the ubiquitination level of p21 was not affected. In addition, the degradation of non-ubiquitinated form of lysine less mutant p21-K6R was also inhibited by IL-1, suggesting that IL-1 stabilized p21 protein via ubiquitin-independent pathway. Furthermore, the inhibition of p21 protein degradation was prevented by a selective inhibitor of ERK1/2 pathway, PD98059. These results suggest that IL-1-induced ERK1/2 activation leads to the up-regulation of p21 by inhibiting degradation via ubiquitin-independent pathway in human melanoma cells A375.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074553     DOI: 10.1016/j.bbrc.2010.01.027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.

Authors:  Yong Qin; Suhendan Ekmekcioglu; Ping Liu; Lyn M Duncan; Gregory Lizée; Nancy Poindexter; Elizabeth A Grimm
Journal:  Mol Cancer Res       Date:  2011-09-27       Impact factor: 5.852

2.  Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.

Authors:  Liqiang Ma; Fenghua Lan; Zhiyong Zheng; Feilai Xie; Lie Wang; Wei Liu; Junyong Han; Feng Zheng; Yanchuan Xie; Qiaojia Huang
Journal:  Mol Cancer       Date:  2012-10-21       Impact factor: 27.401

3.  Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.

Authors:  Alexandra Fullár; Kornélia Baghy; Ferenc Deák; Bálint Péterfia; Yvonne Zsák; Péter Tátrai; Zsuzsa Schaff; József Dudás; Ibolya Kiss; Ilona Kovalszky
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.